$ELV Earnings Preview: Oversold Potential + Key Metrics AheadEarnings Estimates: Analysts forecast an EPS of $3.82 for the upcoming quarter, indicating a 32% year-over-year decline. Revenue is projected at $44.67 billion, a 5.2% increase from the same period last year.
Oversold Potential: With an oversold score of 59%, NYSE:ELV appears attractive for a
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
23.8 EUR
5.78 B EUR
170.79 B EUR
225.49 M
About Elevance Health, Inc.
Sector
Industry
CEO
Gail Koziara Boudreaux
Website
Headquarters
Indianapolis
Founded
1944
FIGI
BBG000BHX743
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Elevance - Short interest declining, buy the dip?The shorts have done extremely well here, dragging the price down by over 34%. ELV has been under severe pressure due to a miss on EPS on their last earnings report. However, they did beat on revenue (by $1.58B) but that did not stop holders exiting their positions.
Unless you're living under a she
ELV buying opportunityNYSE:ELV buying opportunity, in my opinion.
Elevance Health, Inc. (ELV), formerly known as Anthem, Inc., is a health benefits company that provides medical, pharmaceutical, dental, behavioral health, and other insurance-related services to its members. It operates through affiliated health plans
ELV - capitalizing on misses from UNH and HUMNYSE:ELV had a great earnings, beating on top and bottom line estimates and following through with a 10% dividend increase. This comes as NYSE:UNH and NYSE:HUM each disappoint and lower guidance.
ELV has put in a strong consolidation after retracing from 2022 highs. Using a fib fan from the 2
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
ANTM4983288
Elevance Health, Inc. 3.125% 15-MAY-2050Yield to maturity
7.18%
Maturity date
May 15, 2050
US36752AS2
ELEVANCE HE. 21/51Yield to maturity
7.04%
Maturity date
Mar 15, 2051
ANTM4880736
Elevance Health, Inc. 3.7% 15-SEP-2049Yield to maturity
6.90%
Maturity date
Sep 15, 2049
ANTM4153492
Elevance Health, Inc. 4.85% 15-AUG-2054Yield to maturity
6.58%
Maturity date
Aug 15, 2054
AE1J
ELEVANCE HE. 17/47Yield to maturity
6.56%
Maturity date
Dec 1, 2047
ANTM5405192
Elevance Health, Inc. 4.55% 15-MAY-2052Yield to maturity
6.54%
Maturity date
May 15, 2052
ANTM4606236
Anthem, Inc. /Old/ 4.55% 01-MAR-2048Yield to maturity
6.52%
Maturity date
Mar 1, 2048
ELVH5534305
Elevance Health, Inc. 5.125% 15-FEB-2053Yield to maturity
6.37%
Maturity date
Feb 15, 2053
ANTM4153493
Elevance Health, Inc. 4.65% 15-AUG-2044Yield to maturity
6.30%
Maturity date
Aug 15, 2044
ANTM5923067
Elevance Health, Inc. 5.85% 01-NOV-2064Yield to maturity
6.28%
Maturity date
Nov 1, 2064
ANTM3851462
Elevance Health, Inc. 4.625% 15-MAY-2042Yield to maturity
6.23%
Maturity date
May 15, 2042
See all A58 bonds
Related stocks
Frequently Asked Questions
The current price of A58 is 363.3 EUR — it has increased by 0.41% in the past 24 hours. Watch ELEVANCE HEALTH DL-,01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ELEVANCE HEALTH DL-,01 stocks are traded under the ticker A58.
A58 stock has fallen by −3.89% compared to the previous week, the month change is a −9.08% fall, over the last year ELEVANCE HEALTH DL-,01 has showed a −25.81% decrease.
We've gathered analysts' opinions on ELEVANCE HEALTH DL-,01 future price: according to them, A58 price has a max estimate of 514.84 EUR and a min estimate of 376.67 EUR. Watch A58 chart and read a more detailed ELEVANCE HEALTH DL-,01 stock forecast: see what analysts think of ELEVANCE HEALTH DL-,01 and suggest that you do with its stocks.
A58 stock is 0.67% volatile and has beta coefficient of 0.18. Track ELEVANCE HEALTH DL-,01 stock price on the chart and check out the list of the most volatile stocks — is ELEVANCE HEALTH DL-,01 there?
Today ELEVANCE HEALTH DL-,01 has the market capitalization of 82.06 B, it has decreased by −1.00% over the last week.
Yes, you can track ELEVANCE HEALTH DL-,01 financials in yearly and quarterly reports right on TradingView.
ELEVANCE HEALTH DL-,01 is going to release the next earnings report on Jul 16, 2025. Keep track of upcoming events with our Earnings Calendar.
A58 earnings for the last quarter are 11.06 EUR per share, whereas the estimation was 10.55 EUR resulting in a 4.89% surprise. The estimated earnings for the next quarter are 8.32 EUR per share. See more details about ELEVANCE HEALTH DL-,01 earnings.
ELEVANCE HEALTH DL-,01 revenue for the last quarter amounts to 45.08 B EUR, despite the estimated figure of 42.80 B EUR. In the next quarter, revenue is expected to reach 42.70 B EUR.
A58 net income for the last quarter is 2.02 B EUR, while the quarter before that showed 403.78 M EUR of net income which accounts for 399.74% change. Track more ELEVANCE HEALTH DL-,01 financial stats to get the full picture.
Yes, A58 dividends are paid quarterly. The last dividend per share was 1.58 EUR. As of today, Dividend Yield (TTM)% is 1.61%. Tracking ELEVANCE HEALTH DL-,01 dividends might help you take more informed decisions.
ELEVANCE HEALTH DL-,01 dividend yield was 1.77% in 2024, and payout ratio reached 25.39%. The year before the numbers were 1.26% and 23.47% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 4, 2025, the company has 104.2 K employees. See our rating of the largest employees — is ELEVANCE HEALTH DL-,01 on this list?
Like other stocks, A58 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ELEVANCE HEALTH DL-,01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ELEVANCE HEALTH DL-,01 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ELEVANCE HEALTH DL-,01 stock shows the sell signal. See more of ELEVANCE HEALTH DL-,01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.